Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study

出版年份 2016 全文链接

标题

作者

关键词

Romosozumab, Sclerostin antibody, Carcinogenicity, Chronic toxicity, Null antibody

出版物

Volume 81, Issue -, Pages 212-222

出版商

Elsevier BV

发表日期

2016-08-31

DOI

10.1016/j.yrtph.2016.08.010

联系作者

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started